36 results about "Medical abortion" patented technology

The invention relates to the field of medical health-care beverages, in particular to a solid beverage for promoting postpartum rehabilitation and relieving dysmenorrhea. The solid beverage is characterized in that the medicine is prepared from 12 raw materials as follows: angelica sinensis, arillus longan, fructus jujubae, hawthorn fruits, ginseng, flos rosae rugosae, peach seeds, honey-fried licorice roots, dried ginger, cinnamon, brown powdered sugar and dextrin. A preparation method of the medicine comprises steps as follows: with the adoption of a conventional method, the raw materials except the flos rosae rugosae are smashed and ground or ground into powder for screening and drying, then a medicament obtained after drying and screening is uniformly mixed with rose oil prepared with a conventional steam distillation method and flos rosae rugosae residues obtained after rose oil extraction, the mixture is dried and granulated, and solid particles are prepared, dried and subpackaged. A use method is that the solid particles are taken after mixed with boiled water for three times every day, and a bag of 10 g of the solid particles is taken each time. Compared with the prior art, the medicine has the advantage that the solid beverage suitable for patients with dysmenorrhea as well as crowds needing rehabilitation as soon as possible after induced abortion, medical abortion, midtrimester induction of labor and delivery.

The invention relates to a medicament for medical abortion. The medicament for medical abortion is prepared from the following raw materials in parts by weight: tiarella polyphylla, plum blossom, auriculate dichrocephala, sweet-scented osmanthus, blumea megacephala, kousa dogwood, dichocarpum auriculatum, potentilla kleiniana, porana flower, mung bean, purpleflower holly leaf, raphistemma pulchellum, nanocnide, pinfa raspberry root and leaf, orange blossom, earthworm, narrow-leaved lindernia, six-eared blumea, tortoise shell, locust flower, hemistepta lyrata and rhizoma panacis majoris. The medicament for medical abortion has the advantages of easily available raw materials and definite curative effect, and tests show that the effective rate is high and the cost is low.

The invention discloses a traditional Chinese medicinal composition for treating haemorrhage after medical abortion and a preparation method thereof; the traditional Chinese medicinal composition is prepared from the following raw materials according to parts by weight: 6-7.3 parts of motherwort, 1.3-2.2 parts of raw cattail pollen, 1-2.5 parts of trogopterus dung, 1-2.5 parts of radix astragalus, 0.5-1.5 parts of baked ginger, and 0.5-1.5 parts of peach kernel. The traditional Chinese medicinal composition has the effects of eliminating stasis and stopping bleeding, and is applied to treating haemorrhage of uterus blockage, deciduas residue after medical abortion and haemophilia. The invention further discloses a preparation method of the traditional Chinese medicinal composition.

The invention belongs to the technical field of medicine, and relates to a traditional Chinese medicine for treating vaginal bleeding after medical abortion. The traditional Chinese medicine is prepared from the following raw materials in parts by weight: 9-15 parts of Panax ginseng, 20-28 parts of Angelica sinensis, 6-12 parts of Ligusticum chuanxiong, 3-9 parts of Semen Persicae, 2-4 parts of dried ginger, 2-4 parts of processed radix glycyrrhizae, 20-28 parts of Agrimonia pilosa, 20-28 parts of lotus rhizome node, 9-15 parts of Hibiscus rosa-sinensis flower, 7-13 parts of Radix Rubiac Cordifoliae, 6-12 parts of Fineleaf Schizonepeta Herb, 7-13 parts of Paeonia suffruticosa bark, 7-13 parts of ass-hide glue, 2-4 parts of Squama manitis, 3-9 parts of parched Vaccaria segetalis, 3-9 parts of Radix Arnebiae, 3-9 parts of Scrophularia ningpoensis, and 2-4 parts of Panax notoginseng powder. According to clinical trial results, the cure rate is 82.0% and the total effective rate is 98.0% in the observation group of the traditional Chinese medicine provided by the invention, which are both significantly higher than the cure rate (62.5%) and the total effective rate (81.3%) in the control group, with significant difference (P<0.05), the vaginal bleeding period is short, and proportion of the complete curettage of uterine cavity is low.

The invention provides a Chinese medicine compound preparation for preventing and treating the abnormal uterine bleeding after medical abortion, and relates to the gynecologic Chinese medicine field.By taking the anti-early pregnancy drugs, pregnant women can avoid the uteroventral operation, thus the suffering of patients can be relieved; however, the problems of excessive haemorrhage and long bleeding time can occur; the curative effect of the existing medicines is dissatisfactory, and no medicine, which is specially used for treating the abnormal uterine bleeding after medical abortion andhas good curative effect, comprehensive efficacy but no side effect, is reported. The invention takes motherwort as monarch drug, purslane, raw cattail pollen and radix cyathulae as ministerial drugs, bitter orange, agrimony, angelica and radix codonopsitis as adjuvant drugs and liquoric root as envoy drug to prepare the compound preparation. Proved by plenty of clinical experiments, the invention has the advantages of activating blood circulation but no massive haemorrhage, removing stasis, clearing heat, stopping bleeding but no stagnation, nourishing blood, invigorating qi, shortening bleeding time, reducing bleeding amount, no toxic and side effect and convenience for being taken.

The invention relates to a medicament for treating infertility of obstructive uterine tube. The infertility of obstructive uterine tube leads to the clinical symptoms of medical histories such as infertility, pelvic pain, artificial abortion or not and medical abortion. Through an gynecological examination, the adnexa areas at both sides show thickening and have tenderness, and the uterine tube is tested to be completely obstructed or partially obstructed. After a long-term research and clinical verifications, an oral medicament of traditional Chinese medicine for treating infertility of obstructive uterine tube with better curative effect is finally found by the inventor. The dosage of the medicament compositions provided by the invention is also gained through a great deal of development by the inventor and the optimum proportion is as follow: 30 parts of salvia miltiorrhiza, 12 parts of peach seed, 12 parts of cortex moutan, 9 parts of Chinese angelica, 15 parts of szechuan lovage rhizome, 15 parts of radix paeoniae rubra, 9 parts of red flower, 15 parts of bitter orange, 15 parts of dandelion, 15 parts of barbed skullcap herb, 12 parts of stir-baked squama manitis, 15 parts of spina gleditsiae, 3 parts of centipede, 3 parts of pseudo-ginseng and 15 parts of coke hawthorn. Each medicament functions to generate the synergistic effect by combining all which has the effects of activating blood, dissolving stasis and dredging collaterals, and thus effectively treating the infertility of obstructive uterine tube.

The invention discloses application of an alginate oligosaccharide to the preparation of a medicament for facilitating postnatal uterine contraction. The alginate oligosaccharide is obtained by oxidizing and degrading polysaccharide alginate extracted from kelp, and the viscosity is 1-20 cps. The alginate oligosaccharide has the effect of forcibly contracting the uterus, can be prepared into a plurality of dosage forms, is suitable for facilitating postnatal uterine contraction, is used for treating postnatal hemorrhage, postnatal infection as well as subinvolution after medical abortion and induced abortion, and has the advantages and characteristics of remarkable curative effect, low price, safety, convenience and no side effect.

The invention discloses a razor clam extractive used for promoting postpartum uterus contraction; the razor clam extractive is the water-soluble matter extracted from the razor clam meat, has the function of contracting uterus and is used for treating postpartum hemorrhage and incomplete restoration of uterus after medical abortion operation and induced abortion operation.

The invention provides a Chinese medicine compound preparation for preventing and treating the abnormal uterine bleeding after medical abortion, and relates to the gynecologic Chinese medicine field. By taking the anti-early pregnancy drugs, pregnant women can avoid the uteroventral operation, thus the suffering of patients can be relieved; however, the problems of excessive haemorrhage and long bleeding time can occur; the curative effect of the existing medicines is dissatisfactory, and no medicine, which is specially used for treating the abnormal uterine bleeding after medical abortion and has good curative effect, comprehensive efficacy but no side effect, is reported. The invention takes motherwort as monarch drug, purslane, raw cattail pollen and radix cyathulae as ministerial drugs, bitter orange, agrimony, angelica and radix codonopsitis as adjuvant drugs and liquoric root as envoy drug to prepare the compound preparation. Proved by plenty of clinical experiments, the invention has the advantages of activating blood circulation but no massive haemorrhage, removing stasis, clearing heat, stopping bleeding but no stagnation, nourishing blood, invigorating qi, shortening bleeding time, reducing bleeding amount, no toxic and side effect and convenience for being taken.

The invention discloses a sea cucumber flower extractive used for promoting postpartum uterus contraction; the sea cucumber flower extractive is the water-soluble matter extracted from the sea cucumber flower, which is the sea cucumber processing waste. The sea cucumber flower extractive has the function of contracting uterus and is used for treating postpartum hemorrhage and incomplete restoration of uterus after medical abortion operation and induced abortion operation.

The invention discloses a sea cucumber flower extractive used for promoting postpartum uterus contraction; the sea cucumber flower extractive is the water-soluble matter extracted from the sea cucumber flower, which is the sea cucumber processing waste. The sea cucumber flower extractive has the function of contracting uterus and is used for treating postpartum hemorrhage and incomplete restoration of uterus after medical abortion operation and induced abortion operation.

The invention relates to a preparation method for a medicament for treating colporrhagia caused by medical abortion. The method comprises the following steps: adding 22,000ml of water into 9 grams of rubus setchuenensis bur, 6 grams of scutellaria indica, 5 grams of lindera communis, 8 grams of alpinia zerumbet, 6 grams of meliosma rigida, 8 grams of korean raspberry root, 7 grams of japanese pachysandra herb, 3 grams of asparagus fern, 2 grams of pogostemon auricularius, 3 grams of pilea cavaleriei, 6 grams of cold white grass, 7 grams of microcos paniculata, 3 grams of spreading violet, 6 grams of filipendula palmate, 5 grams of campylotropis macrocarpa, 3 grams of great willowherb herb, 6 grams of equisetum silvaticum and 2 grams of dicliptera chinensis, putting the materials into a flask with a condenser, heating the flask under 80 DEG C for 6 hours, filtrating, and collecting filtrate. The medicament for treating the colporrhagia caused by the medical abortion, prepared by the method disclosed by the invention, has a reasonable formula and a definite effect and can effectively treat the colporrhagia caused by the medical abortion.

The invention discloses a nursing package for medical abortion observation and a use method of the nursing package. The structure of the nursing package comprises a nursing package body, the nursing package body comprises a bag body and a bag cover, the inner part of the bag body is provided with a rinsing basin groove, and the inside of the rinsing basin groove is provided with a tissue rinsing basin; the tissue rinsing basin is a flexible folding basin, the basin wall of the tissue rinsing basin is corrugated, the inner wall of the tissue rinsing basin is provided with a layer of filter screen, the bottom of the tissue rinsing basin is connected with a drainage pipe, and the drainage pipe is provided with a water stop clip; and both sides of the rinsing basin groove are respectively provided with a forceps groove and a specimen bag groove, the inside of the forceps groove is provided with a disposable forceps groove, the inside of the specimen bag groove is provided with a specimen bag, and the inner side of the bag cover is provided with a pad mesh pocket and a glove mesh pocket. According to the nursing package of the present invention, the tissue rinsing basin, disposable forceps, the specimen bag, disposable pads and disposable gloves can be placed in the nursing package, and flexible plastic foldable design is adopted in the tissue rinsing basin and and pregnant tissuescan be conveniently received and rinsed, so that the specimen retention is improved and resource waste is reduced.

The invention relates to a medicine for treating metrorrhagia caused after medical abortion. The medicine is prepared from an effective dose of compound with a structural formula described in the description, pharmacologically acceptable salts, esters or prodrugs of the compound, and a pharmacologically acceptable carrier, wherein R1 is hydrogen, C1-6 alkyl, single-halogenated or polyhalogenated C1-6 alkyl, C1-6 alkyl substituted with one or two hydroxy groups, or C1-6 alkyl substituted with one substituent group, and the substituent group is selected from a group consisting of the following items: cyano group and C1-4 alkoxy; R2 is hydrogen, C1-6 alkyl, single-halogenated or polyhalogenated C1-6 alkyl, C1-6 alkyl substituted with one or two hydroxyl groups, or C1-6 alkyl substituted withone substituent group, and the substituent group is selected from a group consisting of the following items: cyano group and C1-4 alkoxy; R3 is hydrogen, C1-4 alkoxy, hydroxyl, cyano group, C1-4 alkylor halogen; R4 is hydrogen, C1-4 alkoxy, hydroxyl, cyano group, C1-4 alkyl or halogen. The medicine has a hemostasis effect on the metrorrhagia caused after medical abortion.

To produce a medicament with a menstruating contraceptive effect, it consists of a sequential oral dosage unit of mifepristone followed by vaginal administration of a dosage unit of misoprostol 36-48 hours later. The invention is convenient to use, adopts oral and vaginal medication, and the dosage is small, the effect is good, the bleeding time is shorter than conventional medical abortion, and anxiety and pain can be relieved without any complication.

The invention relates to a preparation method for a medicament for treating colporrhagia caused by medical abortion. The method comprises the following steps: adding 22,000ml of water into 9 grams of rubus setchuenensis bur, 6 grams of scutellaria indica, 5 grams of lindera communis, 8 grams of alpinia zerumbet, 6 grams of meliosma rigida, 8 grams of korean raspberry root, 7 grams of japanese pachysandra herb, 3 grams of asparagus fern, 2 grams of pogostemon auricularius, 3 grams of pilea cavaleriei, 6 grams of cold white grass, 7 grams of microcos paniculata, 3 grams of spreading violet, 6 grams of filipendula palmate, 5 grams of campylotropis macrocarpa, 3 grams of great willowherb herb, 6 grams of equisetum silvaticum and 2 grams of dicliptera chinensis, putting the materials into a flask with a condenser, heating the flask under 80 DEG C for 6 hours, filtrating, and collecting filtrate. The medicament for treating the colporrhagia caused by the medical abortion, prepared by the method disclosed by the invention, has a reasonable formula and a definite effect and can effectively treat the colporrhagia caused by the medical abortion.

The invention relates to a novel use of ferulic acid, and particularly relates to a novel use of ferulic acid in preparation for a medicine used for relieving uterine bleeding after abortion, wherein ferulic acid can be used for dominantly inducing the protein expressions of the specific nuclear transcription factors of subgroups Th1 and Th17 on the maternal-fetal interface of a mouse which is subjected to medical abortion via mifepristone, reducing the protein expressions of the specific nuclear transcription factors of subgroups Th2 and Treg, and then inducing the migration of T-cells to the subgroups Th1 and Th17 and promoting maternal-fetal immunological rejection, thus reducing the amount of the uterine bleeding of the mouse which is subjected to medical abortion.

The invention relates to medicine used for medical abortion. The medicine comprises, by weight, 50 parts of ginseng fruits, 40 parts of pansy, 35 parts of teucrium viscidum, 30 parts of dracontomelon duperreanum, 30 parts of bearded mallotus roots, 30 parts of lysimachia microcarpa, 20 parts of lawn pennywort herbs, 20 parts of Japanese raspberry roots, 10 parts of lysimachia longipes and 10 parts of elatostema oblohgifolium fu. The raw materials are easy to obtain, the treatment effect is definite, and testing verifies that the effective rate is high, and the cost is low.

The invention provides a traditional Chinese medicine composition for treating and controlling intrauterine residues after medicinal abortion, which is prepared from 200-500 parts of motherwort, 150-450 parts of angelica, 100-300 parts of radix achyranthis bidentatae, 100-300 parts of hemlock parsley, 150-450 parts of baked ginger, 100-300 parts of fructus aurantii and 100-300 parts of safflower. The composition provided by the invention is firmly supported by classical theories of Gynecology in traditional Chinese medicine, and has the advantages of reasonable component proportioning, exact curative effect, and no toxic or side effect. The composition can be made into capsules, granules, tablets and powder, is safe to take, has less medicinal components, and is easy to control the quality. The invention has the advantage of low cost, and can be used for preparing the Chinese medicine composition for preventing and controlling intrauterine residues after medicinal abortion.

The invention discloses application of an alginate oligosaccharide to the preparation of a medicament for facilitating postnatal uterine contraction. The alginate oligosaccharide is obtained by oxidizing and degrading polysaccharide alginate extracted from kelp, and the viscosity is 1-20 cps. The alginate oligosaccharide has the effect of forcibly contracting the uterus, can be prepared into a plurality of dosage forms, is suitable for facilitating postnatal uterine contraction, is used for treating postnatal hemorrhage, postnatal infection as well as subinvolution after medical abortion and induced abortion, and has the advantages and characteristics of remarkable curative effect, low price, safety, convenience and no side effect.

The invention relates to medicine for treating metrorrhagia after medical abortion. The medicine is prepared from following traditional Chinese medical raw materials in parts by weight: 10 to 25 partsof herba phtheirospermum japonicum, 5 to 15 parts of radix eulaliopsis binata, 10 to 20 parts of herba aspidium, 5 to 20 parts of common papermulberry roots, 5 to 10 parts of radix schoenoplectus mucronatus, 20 to 30 parts of siberian elm leaves, 5 to 10 parts of herba eleusine indica, 5 to 8 parts of dictyophora indusiata, 3 to 8 parts of broadleaf sedge roots, 5 to 12 parts of pumpkin stems, 15to 25 parts of black soyabean spermoderm, 10 to 20 parts of apple leaves, 5 to 20 parts of shepherdspurse inflorescence, 3 to 8 parts of fructus tribulus terrestris, 5 to 10 parts of gordon euryale leaves, 5 to 15 parts of radix valeriana officinalis, 4 to 12 parts of herba emilia sonchifolia, 5 to 8 parts of maclura tricuspidata stems and leaves and 3 to 9 parts of rhizoma thalictrum delavayi. The medicine provided by the invention has the advantages that various kinds of medicine are matched; the effects of benefiting qi, nourishing blood, removing stasis, promoting tissue regeneration, cooling blood, stopping bleeding, regulating qi, soothing the nerves, diminishing inflammation and relieving pain are achieved; the uterus bleeding quantity after the medical abortion can be reduced; thebleeding time can be shortened; the curative effect is obvious; the effect taking speed is high; and no toxic and side effects exist.

The invention relates to medicinal use of leonurine, and in particular provides use of leonurine and pharmaceutical salts thereof for improving estradiol (E2) level of human being or mammals or reducing luteinizing hormone (LH) or follicle stimulating hormone (FSH) level of the human being or the mammals. The novel use of the leonurine is beneficial to clinical practice and therapeutic effectiveness of mifepristone and misoprostol on the early pregnancy before artificial abortion, particularly to the treatment of the incomplete womb restoration after parturition or bleeding after medical abortion.

The invention relates to a medicament for treating infertility of obstructive uterine tube. The infertility of obstructive uterine tube leads to the clinical symptoms of medical histories such as infertility, pelvic pain, artificial abortion or not and medical abortion. Through an gynecological examination, the adnexa areas at both sides show thickening and have tenderness, and the uterine tube is tested to be completely obstructed or partially obstructed. After a long-term research and clinical verifications, an oral medicament of traditional Chinese medicine for treating infertility of obstructive uterine tube with better curative effect is finally found by the inventor. The dosage of the medicament compositions provided by the invention is also gained through a great deal of development by the inventor and the optimum proportion is as follow: 30 parts of salvia miltiorrhiza, 12 parts of peach seed, 12 parts of cortex moutan, 9 parts of Chinese angelica, 15 parts of szechuan lovage rhizome, 15 parts of radix paeoniae rubra, 9 parts of red flower, 15 parts of bitter orange, 15 parts of dandelion, 15 parts of barbed skullcap herb, 12 parts of stir-baked squama manitis, 15 parts of spina gleditsiae, 3 parts of centipede, 3 parts of pseudo-ginseng and 15 parts of coke hawthorn. Each medicament functions to generate the synergistic effect by combining all which has the effects of activating blood, dissolving stasis and dredging collaterals, and thus effectively treating the infertility of obstructive uterine tube.

The invention belongs to the technical field of medicine, and particularly relates to nursing medicine used for treating colporrhagia after a medical abortion and a preparation method thereof. The nursing medicine is composed of hairyvein agrimony, astragalus membranaceus, cortex moutan, codonopsis pilosula, dahurian patrinia herbs, rehmannia glutinosa, peach seeds, red paeony roots and other components. The nursing medicine has the significant treatment effects of cooling blood for hemostasis, replenishing qi to strengthen superficial body resistance, replenishing essence and marrow, removing stasis to ease pain and clearing away heat and toxic materials and has an extremely strong targeted nursing effect on colporrhagia after a medical abortion, especially, qi stagnation and blood stasis colporrhagia after a medical abortion; as is proven by clinical application, the nursing medicine is definite in treatment effect, takes effect fast, has no toxic and side effect or untoward effect and can serve as effective nursing medicine for treating colporrhagia after a medical abortion, especially, qi stagnation and blood stasis colporrhagia after a medical abortion.

The invention belongs to the technical field of medicine, and particularly relates to nursing medicine used for treating colporrhagia after a medical abortion and a preparation method thereof. The nursing medicine is composed of hairyvein agrimony, astragalus membranaceus, cortex moutan, codonopsis pilosula, dahurian patrinia herbs, rehmannia glutinosa, peach seeds, red paeony roots and other components. The nursing medicine has the significant treatment effects of cooling blood for hemostasis, replenishing qi to strengthen superficial body resistance, replenishing essence and marrow, removing stasis to ease pain and clearing away heat and toxic materials and has an extremely strong targeted nursing effect on colporrhagia after a medical abortion, especially, qi stagnation and blood stasis colporrhagia after a medical abortion; as is proven by clinical application, the nursing medicine is definite in treatment effect, takes effect fast, has no toxic and side effect or untoward effect and can serve as effective nursing medicine for treating colporrhagia after a medical abortion, especially, qi stagnation and blood stasis colporrhagia after a medical abortion.